Cargando…

CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting

Tyrosine kinase inhibitors (TKIs) are highly effective for the treatment of chronic myeloid leukemia (CML), but very few patients are cured. The major drawbacks regarding TKIs are their low efficacy in eradicating the leukemic stem cells responsible for disease maintenance and relapse upon drug cess...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landberg, Niklas, von Palffy, Sofia, Askmyr, Maria, Lilljebjörn, Henrik, Sandén, Carl, Rissler, Marianne, Mustjoki, Satu, Hjorth-Hansen, Henrik, Richter, Johan, Ågerstam, Helena, Järås, Marcus, Fioretos, Thoas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830390/ https://www.ncbi.nlm.nih.gov/pubmed/29284680 http://dx.doi.org/10.3324/haematol.2017.169946

Ejemplares similares

A high-content cytokine screen identifies myostatin propeptide as a positive regulator of primitive chronic myeloid leukemia cells
por: von Palffy, Sofia, et al.
Publicado: (2020)

IL1RAP is expressed in several subtypes of pediatric acute lymphoblastic leukemia and can be used as a target to eliminate ETV6::RUNX1-positive leukemia cells in preclinical models
por: Ågerstam, Helena, et al.
Publicado: (2022)

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells
por: Askmyr, Maria, et al.
Publicado: (2017)

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML
por: von Palffy, Sofia, et al.
Publicado: (2022)

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells
por: Askmyr, M, et al.
Publicado: (2014)

Clonal competition within complex evolutionary hierarchies shapes AML over time
por: Sandén, Carl, et al.
Publicado: (2020)

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
por: Hansen, N, et al.
Publicado: (2013)

Integrative analysis of gene expression and copy number alterations using canonical correlation analysis
por: Soneson, Charlotte, et al.
Publicado: (2010)

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
por: Lilljebjörn, Henrik, et al.
Publicado: (2016)

Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia
por: Lundin-Ström, Kristina B., et al.
Publicado: (2018)

Transcriptional profiling demonstrates altered characteristics of CD8 (+) cytotoxic T‐cells and regulatory T‐cells in TP53‐mutated acute myeloid leukemia
por: Abolhalaj, Milad, et al.
Publicado: (2022)

Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states
por: Somasundaram, Rajesh, et al.
Publicado: (2016)

Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
por: Chapellier, Marion, et al.
Publicado: (2019)

Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia
por: Gunnarsson, Rebeqa, et al.
Publicado: (2018)

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
por: Mosakhani, Neda, et al.
Publicado: (2013)

Why B(-)other? About the gap of unknowns in ALL
por: Fioretos, Thoas
Publicado: (2022)

PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia
por: Okuyama, Kazuki, et al.
Publicado: (2019)

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line
por: Kreutzman, Anna, et al.
Publicado: (2019)

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
por: Rodriguez-Zabala, Maria, et al.
Publicado: (2023)

FLT3(N676K) drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
por: Hyrenius-Wittsten, Axel, et al.
Publicado: (2019)

Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia
por: Yang, Minjun, et al.
Publicado: (2019)

Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies
por: Andersson, Anna, et al.
Publicado: (2010)

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia
por: El Missiry, Mohamed, et al.
Publicado: (2017)

The primitive soluble permutation groups of degree less than 256
por: Short, Mark W
Publicado: (1992)

High CD34 surface expression in BCP‐ALL predicts poor induction therapy response and is associated with altered expression of genes related to cell migration and adhesion
por: Modvig, Signe, et al.
Publicado: (2022)

An improved method for detecting and delineating genomic regions with altered gene expression in cancer
por: Nilsson, Björn, et al.
Publicado: (2008)

Threshold-free high-power methods for the ontological analysis of genome-wide gene-expression studies
por: Nilsson, Björn, et al.
Publicado: (2007)

Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia
por: Rezayee, Fatemah, et al.
Publicado: (2023)

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
por: Huang, Wen-Kuan, et al.
Publicado: (2020)

The Primitive Thylakoid-Less Cyanobacterium Gloeobacter Is a Common Rock-Dwelling Organism
por: Mareš, Jan, et al.
Publicado: (2013)

Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells
por: Hultmark, Simon, et al.
Publicado: (2020)

Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
por: Subramaniam, Agatheeswaran, et al.
Publicado: (2022)

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
por: Woll, Petter S., et al.
Publicado: (2022)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

Peripheral primitive neuroectodermal tumor: Dynamic CT, MRI and clinicopathological characteristics - analysis of 36 cases and review of the literature
por: Tan, Yan, et al.
Publicado: (2014)

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
por: Ilander, M, et al.
Publicado: (2017)

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2014)

STAT5b in LGL leukemia – a novel therapeutic target?
por: Rajala, Hanna L. M., et al.
Publicado: (2013)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

Primitive art
por: Boas, Franz, 1858-1942

Cannot write session to /tmp/vufind_sessions/sess_ivif315to078qup2tg9thk4lub